Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis

View source ↗

Summary

This study evaluates the prognostic value of cerebrospinal fluid immunoglobulin free light chains in patients with multiple sclerosis and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Francis Corazza | Conditions: Multiple Sclerosis | Status: RECRUITING